openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Tilray, Inc. (NASDAQ: TLRY)

05-15-2020 06:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Tilray, Inc. (NASDAQ: TLRY) shares.

An investigation on behalf of current long term investors in Tilray, Inc. (NASDAQ: TLRY) shares.

An investigation on behalf of current long-term investors in shares of Tilray, Inc. (NASDAQ: TLRY) concerning potential breaches of fiduciary duties by certain directors and officers of Tilray, Inc. was announced.

Investors who are current long term investors in Tilray, Inc. (NASDAQ: TLRY) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: TLRY stocks follows a lawsuit filed against Tilray, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: TLRY stocks, concerns whether certain Tilray directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the purported advantages of the ABG Agreement were significantly overstated, that the underperformance of the ABG Agreement would foreseeably have a significant impact on the Company's financial results, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Tilray, Inc. (NASDAQ: TLRY) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Tilray, Inc. (NASDAQ: TLRY) here

News-ID: 2047775 • Views: 414

More Releases from Shareholders Foundation

Lawsuit filed for Investors in shares of Odonate Therapeutics, Inc. (NASDAQ: ODT …
An investor, who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT), filed a lawsuit over alleged Securities Laws violations by Odonate Therapeutics, Inc. Investors who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 16, 2020. NASDAQ: ODT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. San Diego, CA based Odonate Therapeutics,
Investigation announced for Investors in NASDAQ: PINC over possible Wrongdoing a …
An investigation on behalf of investors in shares of Premier, Inc. (NASDAQ: PINC) was announced over potential breaches of fiduciary duties by certain officers and directors at Premier, Inc. Investors who purchased shares of Premier, Inc. (NASDAQ: PINC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Premier, Inc. directors breached their fiduciary duties and
Deadline on October 9th coming up in Lawsuit for Investors in shares of MEI Phar …
A deadline is coming up on October 9, 2020 in the lawsuit filed for certain investors of MEI Pharma, Inc. (NASDAQ: MEIP) over alleged securities laws violations by MEI Pharma, Inc. Investors who purchased shares of MEI Pharma, Inc. (NASDAQ: MEIP) have certain options and there are strict and short deadlines running. Deadline: October 9, 2020. NASDAQ: MEIP stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Investigation announced for Long-Term Investors in shares of Casper Sleep Inc. ( …
An investigation on behalf of current long-term investors in shares of Casper Sleep Inc. (NYSE: CSPR) concerning potential breaches of fiduciary duties by certain directors and officers of Casper Sleep Inc. was announced. Investors who are current long term investors in Casper Sleep Inc. (NYSE: CSPR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for

All 5 Releases


More Releases for Tilray

Cannabis Market to See massive Growth by 2026 | O.penVAPE Shop, The Cronos, Tilr …
Global cannabis market is projected to register a healthy CAGR of 34.7% in the forecast period of 2020 to 2026. The latest Market report by a Data Bridge Market Research with the title [Global Cannabis Market - Industry Trends and Forecast to 2026] . Cannabis Market research analysis and data lend a hand to businesses for the planning of strategies related to COVID-19 impact on industry, investment, revenue generation, production, product
Medical Cannabis Market Still Going Strong | Tilray, Medreleaf, Aurora Cannabis
Advance Market Analytics released the research report of Global Medical Cannabis Market, offers a detailed overview of the factors influencing the global business scope. Global Medical Cannabis Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Global Medical Cannabis. According to AMA, the Global Medical Cannabis
Deadline on May 5th coming up in Lawsuit for Investors in Tilray, Inc. (NASDAQ: …
A deadline is coming up on May 5, 2020 in the lawsuit filed for certain investors of Tilray, Inc. (NASDAQ: TLRY) over alleged securities laws violations by Tilray, Inc. Investors who purchased shares of Tilray, Inc. (NASDAQ: TLRY) have certain options and there are strict and short deadlines running. Deadline: May 5, 2020. NASDAQ: TLRY stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
CBD Beverages Global Market Study Reveal explosive growth potential | Tilray, Ca …
A new market study is released on Global CBD Beverages Market with data Tables for historical and forecast years represented with Chats & Graphs spread through 110 Pages with easy to understand detailed analysis. The study highlights detailed assessment of the Market and display market sizing trend by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry validated market development data. The research study provides estimates
Medical Cannabis Market 2026: Growth And Revenue Analysis | BOL Pharma, Tilray, …
Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures. The various economies are involved in the activities to legalize the export of medicinal cannabis product, which
Incredible Growth Of Medical Cannabis Market 2026 Growing With Major Eminent Key …
According to the U.S., marijuana was the most widely used drug globally in 2014 with around 183 million users. Such a large user base makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding legalization of the drug for medicinal use. The National Institute on Drug Abuse is conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune disease, pain,